ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer
Margaret M. Centenera(South Australian Health and Medical Research Institute), Lisa M. Butler(South Australian Health and Medical Research Institute)
Cited by 94
Related Papers
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
|eLife|2021|36
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
|British Journal of Cancer|2023|13